Protection against fatal pneumonia through mucosal and subcutaneous immunization with the pneumococcal SP0148 protein

Balakrishnan, 2000, Early predictors of mortality in pneumococcal bacteraemia, J. Infect., 40, 256, 10.1053/jinf.2000.0653 Mook-Kanamori, 2011, Pathogenesis and pathophysiology of pneumococcal meningitis, Clin. Microbiol. Rev., 24, 557, 10.1128/CMR.00008-11 Bogaert, 2004, Streptococcus pneumoniae colonisation: the key to pneumococcal disease, Lancet Infect. Dis., 4, 144, 10.1016/S1473-3099(04)00938-7 Kang, 2013, Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia, J. Infect., 66, 34, 10.1016/j.jinf.2012.08.011 Lynch, 2009, Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention, Semin. Respir. Crit. Care Med., 30, 189, 10.1055/s-0029-1202938 Brooks, 2018, Streptococcus pneumoniae's virulence and host immunity: aging, diagnostics, and prevention, Front. Immunol., 9, 1366, 10.3389/fimmu.2018.01366 Cillóniz, 2016, What is the clinical relevance of drug-resistant pneumococcus?, Curr. Opin. Pulm. Med., 22, 227, 10.1097/MCP.0000000000000262 Pan, 2018, Comparative genomic analysis of multidrug-resistant Streptococcus pneumoniae isolates, Infect. Drug Resist., 11, 659, 10.2147/IDR.S147858 Jansen, 2018, The role of vaccines in fighting antimicrobial resistance (AMR), Hum. Vaccines Immunother., 22, 1 Li, 2015, Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in 2 to 70 year old healthy people in China: a phase III double blind, randomized clinical trial, Hum. Vaccines Immunother., 11, 699, 10.1080/21645515.2015.1011015 Remschmidt, 2016, Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review, BMC Infect. Dis., 16, 711, 10.1186/s12879-016-2040-y Miller, 2011, Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study, Lancet Infect. Dis., 11, 760, 10.1016/S1473-3099(11)70090-1 Hoshi, 2015, Economic evaluation of immunisation programme of 23-valent pneumococcal polysaccharide vaccine and the inclusion of 13-valent pneumococcal conjugate vaccine in the list for single-dose subsidy to the elderly in Japan, PLoS One, 10, 10.1371/journal.pone.0139140 Bogaert, 2014, Pneumococcal vaccines: an update on current strategies, Vaccine, 22, 2209, 10.1016/j.vaccine.2003.11.038 Basavanna, 2009, Screening of Streptococcus pneumoniae ABC transporter mutants demonstrates that LivJHMGF, a branched-chain amino acid ABC transporter, is necessary for disease pathogenesis, Infect. Immun., 77, 3412, 10.1128/IAI.01543-08 Cornick, 2017, The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1, Vaccine, 35, 972, 10.1016/j.vaccine.2016.12.037 Moffitt, 2011, TH17-based vaccine design for prevention of Streptococcus pneumoniae colonization, Cell Host Microbe, 9, 158, 10.1016/j.chom.2011.01.007 Hamel, 2004, Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins, Infect. Immun., 72, 2659, 10.1128/IAI.72.5.2659-2670.2004 Zangari, 2017, Streptococcus pneumoniae transmission is blocked by type-specific immunity in an infant mouse model, mBio, 8, 10.1128/mBio.00188-17 Pichichero, 2016, Next generation protein based Streptococcus pneumoniae vaccines, Hum. Vaccines Immunother., 12, 194, 10.1080/21645515.2015.1052198 Principi, 2018, Development of pneumococcal vaccines over the last 10 years, Expert Opin. Biol. Ther., 18, 7, 10.1080/14712598.2018.1384462 Ghimire-Rijal, 2014, Duplication of genes in an ATP-binding cassette transport system increases dynamic range while maintaining ligand specificity, J. Biol. Chem., 289, 30090, 10.1074/jbc.M114.590992 Shelburne, 2008, The role of complex carbohydrate catabolism in the pathogenesis of invasive streptococci, Trends Microbiol., 16, 318, 10.1016/j.tim.2008.04.002 Plumptre, 2014, AdcA and AdcAII employ distinct zinc acquisition mechanisms and contribute additively to zinc homeostasis in Streptococcus pneumoniae, Mol. Microbiol., 91, 834, 10.1111/mmi.12504 Saxena, 2015, Conserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection in vivo, PLoS One, 10, 10.1371/journal.pone.0118154 Moffitt, 2016, Rationale and prospects for novel pneumococcal vaccines, Hum. Vaccines Immunother., 12, 383, 10.1080/21645515.2015.1087625 Lee, 2014, The immune response of two microbial antigens delivered intradermally, sublingually, or the combination thereof, Microb. Infect., 16, 796, 10.1016/j.micinf.2014.07.013 Sun, 2017, Subcutaneous immunization with Streptococcus pneumoniae GAPDH confers effective protection in mice via TLR2 and TLR4, Mol. Immunol., 83, 1, 10.1016/j.molimm.2017.01.002 Kiyono, 2015, The mucosal immune system: from dentistry to vaccine development, Proc. Jpn. Acad. Ser. B Phys. Biol. Sci., 91, 423, 10.2183/pjab.91.423 Borges, 2010, Mucosal vaccines: recent progress in understanding the natural barriers, Pharm. Res., 27, 211, 10.1007/s11095-009-0011-3 Goulart, 2017, A combination of recombinant Mycobacterium bovis BCG strains expressing pneumococcal proteins induces cellular and humoral immune responses and protects against pneumococcal colonization and sepsis, Clin. Vaccine Immunol., 24, 10.1128/CVI.00133-17 Curtis, 2009, Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens, Immunology, 126, 177, 10.1111/j.1365-2567.2008.03017.x O'Connor, 2010, The dual nature of Th17 cells: shifting the focus to function, Nat. Immunol., 11, 471, 10.1038/ni.1882 Marqués, 2012, Protection against Streptococcus pneumoniae serotype 1 acute infection shows a signature of Th17- and IFN-γ-mediated immunity, Immunobiology, 217, 420, 10.1016/j.imbio.2011.10.012 Wang, 2018, Expression of toll-like receptor 2 by dendritic cells is essential for the DnaJ-ΔA146Ply-mediated Th1 immune response against Streptococcus pneumoniae, Infect. Immun., 3 Hamel, 2004, Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins, Infect. Immun., 72, 2659, 10.1128/IAI.72.5.2659-2670.2004 Wilson, 2015, Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses, Mucosal Immunol., 8, 627, 10.1038/mi.2014.95 Su, 2017, Subcutaneous immunization with fusion protein DnaJ-ΔA146Ply without additional adjuvants induces both humoral and cellular immunity against pneumococcal infection partially depending on TLR4, Front. Immunol., 8, 686, 10.3389/fimmu.2017.00686